Top Stories
-
Variants of the ABCA7 gene accelerate neurodegeneration by reducing the amount of neuropeptide Y, a protein essential for maintaining brain synapses.
Topic
-
Analysis of 1.6 million brain cells from older adults has captured the cellular changes that occur in Alzheimer’s early stages, revealing potential new targets and routes for prevention.
Topic
-
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
Topic
-
ADScreen, a speech-processing algorithm developed at Columbia Nursing, is now being tested in a clinical trial to see if it can help health care workers identify patients with Alzheimer's earlier.
Topic
Latest News
- July 8, 2023
Lecanemab, marketed as Leqembi, is the first drug for Alzheimer’s disease to receive approval on the basis of clinically slowing the progression of Alzheimer’s disease.
Topic
- May 2, 2023
Attending a high school with a high number of teachers with graduate training was the clearest predictor of the impact of school quality on late-life cognition, researchers found.
Topic
- April 24, 2023
Columbia Nursing researchers are using AI analysis of voice recordings to find a quick, inexpensive way to screen home care patients for early dementia.
Topic
- April 20, 2023
Columbia neurologists are investigating a set of blood tests that, used in combination with memory tests, may help physicians correctly diagnose Alzheimer disease in low-resource environments.
Topic
- March 31, 2023
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
Topic
- January 26, 2023
Indira Turney, an associate research scientist in the Department of Neurology, is studying how lived experiences affect they way the brain ages in diverse populations.
Topic
- October 24, 2022
In a nationally representative study of cognitive impairment prevalence, Columbia researchers found almost 10% of older adults have dementia and 22% have mild cognitive impairment.
Topic
- July 5, 2022
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
Topic
- May 24, 2022
A gene called FMNL2 may explain why people with hypertension, diabetes, heart disease, or obesity have a greater risk of developing Alzheimer's disease.
Topic
- February 15, 2022
One of the cell's most common proteins may become too old and too stable in Alzheimer’s disease, altering neuronal activity and impairing memory.
Topic
